What is the actual cost of providing the intrauterine system for contraception in a UK community sexual and reproductive health setting?

被引:7
作者
Cook, Louise [1 ]
Fleming, Charlotte [1 ]
机构
[1] Llanfrechfa Grange Hosp, Aneurin Bevan Hlth Board Sexual & Reprod Healthca, Cwmbran, Gwent, Wales
关键词
D O I
10.1136/jfprhc-2012-100377
中图分类号
D669 [社会生活与社会问题]; C913 [社会生活与社会问题];
学科分类号
1204 ;
摘要
Background The anticipated increase in uptake of intrauterine system (IUS) fittings is slower than predicted by the National Institute for Health and Clinical Excellence (NICE). There is evidence to suggest that this is because of a high perceived cost of providing this contraceptive method. Whereas studies to date have all guessed at these costs, we calculated the actual costs of providing the IUS. Methods We tracked the notes of 283 women who had an IUS fitted in our community sexual and reproductive health service for 5 years. We recorded duration of use, measured the actual cost of all appointments and interventions over the lifespan of the device, and compared our findings with NICE predicted costs. Results With 70% complete follow-up, the average duration of use of the IUS was 3.44 years compared to NICE's prediction of 3.32. The average annual cost of providing an IUS for contraception in community clinics was 54.55 pound per woman; this compares with 70.49 pound modelled by NICE for provision in primary care. Most (80%) of the cost is incurred in the first year. The cost of managing problems is small. Conclusions Providing the IUS for contraception was 23% cheaper in the present study than that predicted by NICE and cheaper than providing combined oral contraception in our service. Fitting IUSs in community clinics may be cheaper than in primary care. Streamlining the patient pathway will reduce costs further. Restricting access to the IUS because of initial cost is a false economy.
引用
收藏
页码:46 / U55
页数:8
相关论文
共 22 条
  • [1] [Anonymous], 2001, PRIM CULT PROF QUAL
  • [2] [Anonymous], ASS US EST POP BENCH
  • [3] Armstrong N, 2005, EC SEXUAL HLTH FINDI
  • [4] Benefit-risk-assessment of the levonorgestrel intrauterine system in contraception
    Backman, T
    [J]. DRUG SAFETY, 2004, 27 (15) : 1185 - 1204
  • [5] Length of use and symptoms associated with premature removal of the levonorgestrel intrauterine system: a nation-wide study of 17,360 users
    Backman, T
    Huhtala, S
    Blom, T
    Luoto, R
    Rauramo, I
    Koskenvuo, M
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2000, 107 (03): : 335 - 339
  • [6] Economic analysis of contraceptives for women
    Chiou, CF
    Trussell, J
    Reyes, E
    Knight, K
    Wallace, J
    Udani, J
    Oda, K
    Borenstein, J
    [J]. CONTRACEPTION, 2003, 68 (01) : 3 - 10
  • [7] *DEP HLTH, 2007, FIND BAS REV CONTR S
  • [8] Department of Health, PAYM RES NAT TAR 201
  • [9] Department of Health, PAYM RES NAT TAR 200
  • [10] Faculty of Sexual and Reproductive Health Care Clinical Effectiveness Unit, 2007, INTR CONTR